Xiaoping Su
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 18
- RNA modifications and cancer 11
- Renal and related cancers 11
-
- Cancer-related molecular mechanisms research 19
- Cancer Genomics and Diagnostics 13
- Co-authors
- James R. Downing (17 shared papers)Charles G. Mullighan (15 shared papers)Christopher B. Miller (7 shared papers)Jing Ma (9 shared papers)Sheila Shurtleff (8 shared papers)Xuetao Cao (9 shared papers)Ching‐Hon Pui (6 shared papers)Elaine Coustan‐Smith (4 shared papers)
- Journals
- Blood (19 papers)Journal of Clinical Oncology (10 papers)Cancer Research (10 papers)Proceedings of the National Academy of Sciences (6 papers)Oncotarget (6 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Xiaoping Su
165 papers receiving 12.1k citations
Xiaoping Su's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 3.0k
- Hematology 1.9k
- Oncology 2.5k
- Genetics 862
- Public Health, Environmental and Occupational Health 2.2k
Countries citing papers authored by Xiaoping Su
This map shows the geographic impact of Xiaoping Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Su more than expected).
Fields of papers citing papers by Xiaoping Su
This network shows the impact of papers produced by Xiaoping Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Su. The network helps show where Xiaoping Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Hit paper breakdown → | 2007 | 1243 |
| 2 | PD-L1 Expression in Triple-Negative Breast Cancer Hit paper breakdown → | 2014 | 1089 |
| 3 | Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression Hit paper breakdown → | 2017 | 952 |
| 4 | Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia Hit paper breakdown → | 2009 | 623 |
| 5 | Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 Hit paper breakdown → | 2015 | 619 |
| 6 | Radial glia cells are candidate stem cells of ependymoma Hit paper breakdown → | 2005 | 582 |
| 7 | Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia Hit paper breakdown → | 2008 | 547 |
| 8 | Large-Scale Sequence Analysis of Avian Influenza Isolates Hit paper breakdown → | 2006 | 509 |
| 9 | 2014 | 261 | |
| 10 | 2015 | 258 | |
| 11 | 2008 | 246 | |
| 12 | 2011 | 244 | |
| 13 | 2014 | 216 | |
| 14 | 2019 | 214 | |
| 15 | 2007 | 176 | |
| 16 | 2014 | 163 | |
| 17 | 2019 | 161 | |
| 18 | 2013 | 156 | |
| 19 | 2009 | 128 | |
| 20 | 2019 | 122 |
About Xiaoping Su
Xiaoping Su is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 176 papers that have together received 12.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), Epigenetics and DNA Methylation (18 papers), Renal cell carcinoma treatment (18 papers), Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (13 papers), Cancer Genomics and Diagnostics (13 papers), RNA modifications and cancer (11 papers) and Renal and related cancers (11 papers). The work is most often cited by research in Cancer Research (3.0k citations), Hematology (1.9k citations), Oncology (2.5k citations), Genetics (862 citations) and Public Health, Environmental and Occupational Health (2.2k citations). Xiaoping Su has collaborated with scholars based in United States, China and France. Frequent co-authors include James R. Downing, Charles G. Mullighan, Christopher B. Miller, Jing Ma, Sheila Shurtleff, Xuetao Cao, Ching‐Hon Pui, Elaine Coustan‐Smith, Letha A. Phillips and James Dalton. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Proceedings of the National Academy of Sciences and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.